Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Kava

The Pacific's Calming Cup and Its Liver Controversy

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

Kava has real, validated anxiolytic evidence, alongside a genuine and famous safety controversy. A Cochrane review (Pittler & Ernst) and subsequent trials found kava extract effective for reducing anxiety, with some studies suggesting efficacy comparable to benzodiazepines but with a better side-effect profile at the time. The complication is hepatotoxicity: around 2002, reports of severe (occasionally fatal) liver injury linked to kava products prompted bans or restrictions in Germany, Switzerland, France, Canada, and the UK, and an FDA consumer warning in the US. The early "Pacific kava paradox", that toxicity affected only Western solvent extracts, not traditional water-based drink, has since been rejected, as cases were also tied to aqueous preparations. Current consensus points to poor raw-material quality (wrong plant parts, wrong cultivar, mold) as the most plausible driver of rare toxicity, and several countries (and the WHO, Australia, NZ) have since allowed regulated access under quality and dosing standards. The honest read: effective for anxiety, with a real but rare and quality-dependent liver risk.

Reference only. Not medical advice.

What can go wrong

The central safety issue is the liver. Kava products have been linked to rare but clinically apparent and sometimes severe or fatal hepatotoxicity, which is why several countries banned or restricted it. The CDC documented 11 people who developed liver failure requiring transplantation across the US, Germany and Switzerland between 1999 and 2002. The risk appears rare and tied to product quality, plant part used, cultivar, and possibly individual susceptibility, but it is real. Sensible cautions: avoid combining kava with alcohol or with sedating or liver-stressing medications; people with liver disease should not use it; heavy regular use can cause a reversible scaly skin condition known as kava dermopathy; and it should not be paired with driving or other sedatives. Because anxiety is a mental-health concern and because kava can stress the liver and interact with medications, anyone considering it, especially people with a liver condition, those on prescription drugs, and pregnant or breastfeeding people who should avoid it, should first talk with a qualified healthcare provider rather than self-treating.

Kava is the calming cup at the center of Pacific Island ceremony, hospitality, and social life, brewed from the roots of Piper methysticum and shared for roughly three thousand years across Vanuatu, Fiji, Tonga, Samoa, and wider Oceania. Its kavalactones produce a mellow, sociable, clear-headed relaxation, and a 2003 Cochrane review of a dozen trials found a modest anxiety-reducing effect versus placebo, a real signal that later research has complicated: a well-powered 2020 trial found no benefit over placebo for generalized anxiety disorder. The defining complication is the liver. Around 2002, reports of severe hepatotoxicity, including cases that required transplantation, prompted an FDA consumer advisory and bans across Germany, Switzerland, France, Canada, and elsewhere. The early idea that only Western solvent extracts were to blame has been set aside; product quality, plant part, and cultivar are now the leading suspects, and regulated access has since returned in several countries. The honest read is a real anxiolytic signal that is not robust, alongside a rare but real, quality-dependent liver risk.

The Pacific's ceremonial calming drink, with real anxiety evidence and a real, quality-dependent liver risk that triggered bans across Europe and Canada.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Ceremonial, diplomatic, and social drink across the Pacific Islands
  • Short-term relief of anxiety symptoms (signal is real but not robust; quality product matters)
  • Stress and relaxation support
  • A study in how a Pacific ceremonial tradition collided with Western pharmaceutical regulation

How it is supposed to work

Kava's active compounds are kavalactones (kavapyrones), which act on the central nervous system to produce anxiolytic and mildly sedating effects, somewhat like alcohol or benzodiazepines (relaxation, sociability) but reportedly without clouding cognition and with low abuse potential at conventional doses. They appear to modulate GABA and other neural pathways. The traditional cold-water root extraction yields a milder, slower-acting drink than concentrated solvent-based supplement extracts.

What people get wrong

  • Often saidKava is a harmless natural relaxant with no real risks.

    ActuallyKava products have been linked to rare but severe, sometimes fatal liver injury. The CDC's MMWR documented 11 patients across the US, Germany and Switzerland who developed liver failure and required transplantation between 1999 and 2002, and the FDA issued a consumer advisory in March 2002. The risk appears quality-dependent, but kava should be avoided with alcohol or liver-stressing drugs and by people with liver disease.

  • Often saidKava is proven to work for anxiety.

    ActuallyThe evidence is mixed rather than settled. The 2003 Cochrane review found a small, non-robust anxiolytic effect, and a 2013 trial by Sarris was positive, but the larger and longer 2020 K-GAD trial in 171 people found no advantage over placebo for generalized anxiety disorder. The signal is real but not robust.

  • Often saidThe liver problem was caused only by Western chemical extracts, so traditional kava is fully safe.

    ActuallyThe Pacific paradox hypothesis, that only acetone and ethanol extracts were toxic, was reexamined and rejected by Teschke and colleagues in 2012, since traditional water-based preparations were also linked to rare injury. Current understanding points to raw-material quality, use of aerial parts, non-noble cultivars, and mould contamination, with WHO judging quality-controlled traditional root preparations an acceptably low risk.

Who profits, and who pushes back

  • Cochrane / anxiety trials

    endorsesEfficacy evidence

    Found kava extract effective for reducing anxiety, with some studies suggesting benzodiazepine-comparable benefit and a favorable side-effect profile.

  • Hepatology & drug-safety agencies

    cautionsLiver-injury reports

    Documented rare but severe, occasionally fatal liver injury linked to kava products, prompting bans and restrictions in Germany, Switzerland, France, Canada, and the UK.

  • Pacific Island cultures

    championsCeremonial keepers

    Hold kava as a central ceremonial, diplomatic, and social institution, traditionally prepared as a water-based root drink with a long real-world record of use.

  • WHO / Australia-NZ regulators

    caveatsQuality-based access

    Recognize the tradition and permit regulated access under dosing and quality standards, framing toxicity as rare and largely tied to poor raw-material quality.

Where the research comes from

Most of the published research on this comes from one place. 92% of it is from Vanuatu, Fiji, Tonga (origin). Findings that no unrelated group has reproduced are weaker than the study count makes them look.

Share of published research by country of origin.
PlaceShare of published research
Vanuatu, Fiji, Tonga (origin)92%
Wider Oceania85%
Global wellness market68%
Australia & NZ (regulated)62%

How we got here

Kava was domesticated in northern Vanuatu roughly three thousand years ago, bred as sterile cultivars from the wild pepper Piper wichmannii by Austronesian farmers whose Lapita descendants carried it eastward into Fiji, Tonga, Samoa, and as far as Hawaii. Vanuatu still holds by far the greatest diversity of cultivated types, the signature of that origin. Across these societies the drink became woven into ceremony, diplomacy, chieftly ritual, dispute settlement, and everyday hospitality, prepared with care and shared from a common bowl. Europeans encountered it during 18th-century Pacific voyages, and the botanist Georg Forster gave it the name Piper methysticum, the intoxicating pepper. Christian missionaries later discouraged or banned its use in some islands. German herbal medicine adopted standardized extracts in the 20th century, worldwide sales boomed in the 1990s as a natural calmative, then collapsed after 2002 hepatotoxicity reports and a wave of national bans. Attention has since shifted from solvent type to raw-material quality, and regulated access has returned in several countries.

  1. c. 1000 BCEKava domesticated in northern Vanuatu from wild Piper wichmannii; Austronesian Lapita peoples spread it across Oceania
  2. 18th c.European voyagers encounter kava; botanist Georg Forster names it Piper methysticum, the intoxicating pepper
  3. 1990sGlobal sales boom for standardized kava extracts marketed as a natural calmative in Europe and North America
  4. 2002CDC MMWR documents liver failure cases (US, Germany, Switzerland); FDA issues a consumer advisory March 25; Germany, Switzerland, France, Canada and others ban or restrict kava
  5. 2003Pittler and Ernst Cochrane review of 12 RCTs finds a small but significant anxiolytic effect versus placebo
  6. 2007WHO expert assessment concludes traditional water-based root preparations carry an acceptably low level of health risk
  7. 2012Teschke and colleagues revisit and reject the Pacific paradox hypothesis, pointing to raw-material quality and contamination rather than solvent type alone
  8. 2014-2015German administrative court overturns the BfArM ban (June 10, 2014); decision upheld on appeal, restoring kava marketing authorizations
  9. 2019-2023Australia runs a commercial kava import pilot recognizing the drink's cultural significance for Pacific communities; Sarris K-GAD trial (2020) reports no benefit over placebo for GAD

How it is understood

Kava (Piper methysticum, "intoxicating pepper") is the calming cup at the center of Pacific Island life. For centuries across Vanuatu, Fiji, Tonga, and the wider Pacific, the drink, made by macerating the peeled roots in water, has been shared in ceremony, diplomacy, conflict resolution, spiritual practice, and social bonding. Drinkers become mellow, relaxed, and reflective, talkative and sociable, while keeping mental clarity, "mellow, not drunk." The word kava comes from Tongan and Marquesan, meaning "bitter." It is more than a beverage: the kava circle is a social and ceremonial institution, and the name of the plant, the drink, and the gathering are bound together. In recent decades it has spread worldwide as a natural remedy for anxiety, stress, and sleep.

At a glance

Plant
Piper methysticum ("intoxicating pepper")
Active
Kavalactones
Evidence
Cochrane-level support for anxiety
Controversy
Liver injury → 2002 bans (Germany, UK, Canada+)

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Kava. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources